4.3 Review

Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo

期刊

JOURNAL OF IMMUNOLOGY RESEARCH
卷 2022, 期 -, 页码 -

出版社

HINDAWI LTD
DOI: 10.1155/2022/6952299

关键词

-

资金

  1. Science and Engineering Research Board, Department of Science and Technology (SERB-DST), New Delhi, India [ECR/2017/000858, CRG/2021/002419]
  2. SERB-DST, New Delhi
  3. Knowledge Consortium of Gujarat, Department of Education Government of Gujarat

向作者/读者索取更多资源

Vitiligo is a noncontagious autoimmune skin depigmenting disease. This meta-analysis study explores the role of regulatory T cells (Tregs) in vitiligo pathogenesis and finds that vitiligo patients have reduced Tregs' frequency, suppressive capacity, and key suppressive molecules such as FOXP3, IL-10, and TGF-beta. The study also suggests that Treg-based therapeutic interventions could be effective in vitiligo patients, supported by the increased Tregs' frequency and suppressive molecule expression after certain treatments.
Vitiligo is a noncontagious autoimmune skin depigmenting disease. Regulatory T cells (Tregs) play a key role in maintaining peripheral tolerance; however, Tregs' number, suppressive function, and associated suppressive molecules (FOXP3, IL-10, and TGF-beta) are found to be reduced in vitiligo patients. Although, the role of Tregs in vitiligo pathogenesis is well established, there are several contrary findings which suggest a controversial role of Tregs in vitiligo. Therefore, to clarify the role of Tregs in vitiligo pathogenesis, we aimed to study Tregs' frequency, suppressive capacity, and associated suppressive molecules (FOXP3, IL-10, and TGF-beta) in vitiligo patients through meta-analysis approach. A total of 30 studies involving 1223 vitiligo patients and 1109 controls were included in the study. Pooled results from our meta-analysis suggested significantly reduced Treg cells' frequency in vitiligo patients (p=0.002). Interestingly, Tregs' suppressive capacity was also significantly reduced in vitiligo patients (p=0.0002); specifically, Treg-mediated suppression of CD8(+)T cells was impaired in vitiligo patients (p < 0.00001). Moreover, FOXP3, a key Tregs' transcription factor, was significantly reduced in blood and skin of vitiligo patients (p < 0.00001). Intriguingly, the FOXP3 expression was significantly reduced in the lesional skin as compared to perilesional and nonlesional skin (p=0.007 and p=0.04). Furthermore, the expression of key Treg-associated suppressive cytokines IL-10 and TGF-beta were significantly reduced in vitiligo patients (p=0.0005 and p=0.01). The disease activity-based analysis suggested for reduced Tregs' frequency and FOXP3 expression in active vitiligo patients (p=0.05 and p=0.01). We also studied the effect of microRNA-based treatment, narrow band-UVB phototherapy, and Treg-associated treatments on Tregs' frequency, FOXP3, and IL-10 expression. Interestingly, we found increased Tregs' frequency, FOXP3, and IL-10 expression after the treatment (p=0.007, p < 0.0001, and p=0.002). Overall, our meta-analysis suggests that the Tregs play a crucial role in pathogenesis and progression of vitiligo, and hence, Treg-based therapeutic interventions could be effective in vitiligo patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据